Cargando…

PReS13-SPK-1588: Recurrent fevers

Detalles Bibliográficos
Autor principal:	Frenkel, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Invited Speaker Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043387/ http://dx.doi.org/10.1186/1546-0096-11-S2-I20

Ejemplares similares

PReS13-SPK-1469: Juvenile scleroderma
por: Zulian, F
Publicado: (2013)

PReS13-SPK-1033: Neonatal lupus
por: Cimaz, R
Publicado: (2013)

PReS13-SPK-1030: Juvenile dermatomyositis
por: Quartier, P
Publicado: (2013)

PReS13-SPK-1575: Science of pain amplification
por: Howard, RF
Publicado: (2013)

PReS13-SPK-1082: Catastrophic antiphospholipid syndrome
por: Cervera, R
Publicado: (2013)

PReS13-SPK-1129: Biologic therapies in SLE
por: Isenberg, DA
Publicado: (2013)

PReS13-SPK-1292: Gut microbiome and metabolism
por: Tilg, H
Publicado: (2013)

PReS13-SPK-1127: Pediatric rheumatology in India
por: Khubchandani, RP
Publicado: (2013)

PReS13-SPK-1576: Unmeet needs in JIA treatment
por: Ruperto, N
Publicado: (2013)

PReS13-SPK-1592: Pediatric aspects of antiphospholipid syndrome
por: Avcin, T
Publicado: (2013)

PReS13-SPK-1240: New aspects on APS pathogenesis
por: Meroni, PL
Publicado: (2013)

PReS13-SPK-1034: looking for new monogenic forms of lupus
por: Crow, Y
Publicado: (2013)

PReS13-SPK-1107: Development of an academic pediatric rheumatology program
por: Laxer, R
Publicado: (2013)

PReS13-SPK-1472: Science of muscle training in inflammatory disease
por: Van Brussel, M
Publicado: (2013)

PReS13-SPK-1277: Role of ß2GPI in APS
por: De Groot, PP
Publicado: (2013)

PReS13-SPK-1321: Expanding clinical spectrum of autoinflammatory diseases
por: Aksentijevich, I
Publicado: (2013)

PReS13-SPK-1590: Relevance of cytokine in pediatric inflammatory disease
por: De Benedetti, F
Publicado: (2013)

PReS13-SPK-1579: Biologic agents for the treatment of rheumatic diseases
por: Emery, P
Publicado: (2013)

PReS13-SPK-1572: The therapy management of pain amplification syndrome
por: Maillard, S
Publicado: (2013)

PReS13-SPK-1283: Pathogenesis, diagnosis and management of neuropsychiatric SLE
por: Boumpas, D
Publicado: (2013)

PReS13-SPK-1253: Challenges in nursing care with the new biologics for JIA
por: Livermore, P
Publicado: (2013)

PReS13-SPK-1582: Activity and damage - we have to measure them
por: Feldman, BM
Publicado: (2013)

PReS13-SPK-1322: Autoinflammatory in nature: what patients teach us
por: Gattorno, M
Publicado: (2013)

PReS13-SPK-1137: New developments in our care & understanding of JIA
por: Beresford, MW
Publicado: (2013)

PReS13-SPK-1350: Autoimmune responses following vaccination in healthy populations
por: Toplak, N
Publicado: (2013)

PReS13-SPK-1478: New developments in our care & understanding of JIA
por: Wedderburn, L
Publicado: (2013)

PReS13-SPK-1028: Activity and damage - we have to measure them
por: Brunner, H
Publicado: (2013)

PReS13-SPK-1212: Vaccination in paediatric patients with auto-immune and autoinflammatory diseases
por: Wulfraat, N
Publicado: (2013)

PReS13-SPK-1332: Assessment of disease activity and damage in juvenile idiopathic arthritis
por: Ravelli, A
Publicado: (2013)

PReS13-SPK-1577: 'Asia' - autoimmune (auto-inflammatory) syndromes induced by adjuvants
por: Shoenfeld, YY
Publicado: (2013)

PReS13-SPK-1587: New biologic targets for the future and basic science behind them
por: Prakken, B
Publicado: (2013)

PReS13-SPK-1247: Activity and damage in juvenile systemic sclerosis- we have to measure them
por: Foeldvari, I
Publicado: (2013)

PReS13-SPK-1182: Six years of eu paediatric regulation - what was achieved for paediatric rheumatology
por: Vesely, R
Publicado: (2013)

PReS13-SPK-1586: Biological agents for the treatment of rheumatic diseases: present and future targets of biologic therapy
por: Mcinnes, I
Publicado: (2013)

PReS13-SPK-1408: New EU scientific guidelines for JIA, SLE and GIOP from the European Medicines Agency
por: Vesely, R
Publicado: (2013)

Autoinflammation and immunodeficiency
por: Frenkel, Joost
Publicado: (2014)

Pre-exposure prophylaxis against HIV: pros and cons
por: Wainberg, Mark
Publicado: (2012)

PReS-FINAL-2194: Evidence-based clinical classification criteria for periodic fevers
por: Federici, S, et al.
Publicado: (2013)

S82. Proffered paper: In-vivo testing of PSMA-targeted T-cell immunotherapy for prostate cancer
por: Liu, Z, et al.
Publicado: (2014)

S47. Tumour infiltrating lymphocytes - a predictive marker?
por: Galon, J
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_nmspfkdbjegit4qopm2vb6lg2h